SCHD ETF reached a fresh 52-week high of $32.25, extending its advance as investors looked for lower-volatility equity exposure amid stretched large-cap growth valuations. The move put the dividend-focused fund at the top of its 52-week range of $25.70 to $32.26.
The rally matters because SCHD, formally the Schwab U.S. Dividend Equity ETF, now sits at the intersection of several market themes: a defensive rotation, higher-for-longer rate expectations, and renewed demand for quality income. With $92.77 billion in assets under management and an expense ratio of just 0.06%, it remains one of the largest and lowest-cost dividend ETFs in the market.
Its latest annual reconstitution has also changed the portfolio mix in a meaningful way. Consumer staples, health care, energy and industrials still dominate, but technology has become a more prominent sleeve, giving SCHD a slightly different balance of defense, income and earnings resilience.
Key Facts
- SCHD closed at $32.25, up 0.40% on the session, and touched $32.26, marking a new 52-week high.
- The fund manages $92.77 billion in assets and charges a 0.06% expense ratio.
- SCHD’s trailing 12-month dividend yield stands at 3.29%, based on an annual distribution rate of $1.06 per share.
- Post-reconstitution sector weights include consumer staples at 19.39%, health care at 18.82%, energy at 16.87%, industrials at 11.46% and information technology at 11.07%.
- The ETF trades at just over 15 times trailing earnings, compared with a 20.88 forward price-to-earnings multiple for the S&P 500.
SCHD ETF
SCHD ETF has long been viewed as a core vehicle for dividend investors, but its current setup is drawing attention for a different reason: relative positioning. In a market still heavily influenced by mega-cap technology, SCHD offers a noticeably different sector profile. Its technology exposure remains well below the concentration seen in broad-market benchmarks, while its larger stakes in consumer staples, health care and energy create a more balanced risk profile.
That matters for investors worried about valuation risk in growth-heavy indices. SCHD’s methodology screens for companies with at least 10 consecutive years of dividend payments, while also emphasizing factors such as cash flow to debt and return on equity. The result is a portfolio tilted toward mature businesses with stronger profitability and more established shareholder-return policies than many high-growth peers.
The March 2026 reconstitution added another layer to the story. Technology is now a top-five sector rather than a minimal allocation, with holdings such as Texas Instruments, Qualcomm and Accenture broadening the fund’s earnings base. At the same time, sizable allocations to Chevron, ConocoPhillips and SLB leave SCHD more exposed to any sustained strength in oil prices than the broader S&P 500.
SCHD is increasingly being treated not just as a dividend fund, but as a lower-volatility equity allocation with a meaningful valuation cushion.
How the Rebalancing Changed the Fund
The annual reconstitution materially altered SCHD’s makeup without abandoning its core identity. Consumer staples remains the largest sector at 19.39%, followed by health care at 18.82% and energy at 16.87%. Those are classic defensive and cash-generative areas of the market. However, information technology at 11.07% now plays a more visible role than many long-time holders may expect.
This shift is important because it gives the fund selective exposure to technology companies that pay dividends and generate consistent free cash flow, rather than relying on the highest-multiple names that dominate market-cap-weighted benchmarks. Investors are not buying the most speculative corner of the AI trade through SCHD; they are buying profitable firms with established dividend records and comparatively moderate valuations.
Implications for Investors
For portfolio construction, SCHD offers a middle ground between broad equity exposure and pure income instruments. Its 3.29% trailing yield is above that of the broader market, but the fund’s appeal goes beyond current income. Investors also get a decade-long record of dividend growth, broad diversification across high-quality U.S. companies, and a fee structure that is difficult for active income strategies to match.
The main opportunity is relative resilience. If equity markets become more selective, or if high-valuation growth stocks face multiple compression, SCHD may hold up better than more technology-heavy benchmarks. Its overweight positions in staples, health care and energy could help cushion volatility, especially in periods when earnings durability and cash returns become more valuable than aggressive revenue growth forecasts.
The risks are also clear. SCHD can lag in a strong momentum-driven rally led by mega-cap technology, particularly if investor appetite for growth accelerates again. Its yield, while attractive, has compressed as the share price has risen, which means new buyers are entering at a richer valuation than they would have seen earlier in the cycle. And while the energy allocation can be a tailwind when crude prices are elevated, it can also become a source of underperformance if commodity prices retreat sharply.
Investors should also monitor the fund’s technical and valuation backdrop. The breakout to a 52-week high suggests strong recent demand, but fresh highs can invite profit-taking if broader market sentiment weakens. Key watch points include dividend growth from major holdings, sector performance versus the S&P 500, and whether the newer technology sleeve contributes to returns without materially increasing volatility.
SCHD’s advance to a new high underscores how quickly the market can reprice quality and defense when leadership begins to broaden. If the current rotation persists, the ETF could remain a favored option for investors seeking income, lower fees and a more conservative equity profile over the next several quarters.
VIP Trading Signals
